Inventor · disambiguated record
Sophie Lucas
Also filed as: LUCAS SOPHIE
21 granted patents·4 pending applications·183 citations·filing 1995–2023
94Inventor score
Files withLUDWIG INST CANCER RES9LUDWIG INST FOR CANCER RES LTD5ARGENX BVBA4INST NAT SANTE RECH MED2UNIV CATHOLIQUE LOUVAIN2
Top patents by PatentIndex Score
25 records- 0193US10000572B2Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibodyLUDWIG INST FOR CANCER RES LTD·Filed 2014·Granted Jun 19, 2018·22 cites·8 claims
- 0287US10793627B2GARP-TGF-β 1 IGG antibodiesARGENX BVBA·Filed 2019·Granted Oct 6, 2020·2 cites·1 claims
- 0386US6130052ALeukemia associated genesLUDWIG INST CANCER RES·Filed 1998·Granted Oct 10, 2000·89 cites·8 claims
- 0482US10875914B2Nucleic acids encoding GARP-TGF-beta 1 antibodiesARGENX BVBA·Filed 2019·Granted Dec 29, 2020·1 cites·18 claims
- 0581US10822424B2Method of screening for anti-GARP antibodiesUNIV CATHOLIQUE LOUVAIN·Filed 2019·Granted Nov 3, 2020·1 cites·12 claims
- 0678US10479829B2GARP-TGF-beta 1 antibodiesARGENX BVBA·Filed 2018·Granted Nov 19, 2019·1 cites·16 claims
- 0774US7998483B2Lage-1 tumor associated nucleic acidsLUDWIG INST FOR CANCER RES LTD·Filed 2009·Granted Aug 16, 2011·0 cites·4 claims
- 0871US5821122AIsolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereofLUDWIG INST CANCER RES·Filed 1995·Granted Oct 13, 1998·17 cites·16 claims
- 0970US11230603B2Anti-GARP proteinLUDWIG INST FOR CANCER RES LTD·Filed 2020·Granted Jan 25, 2022·0 cites·15 claims
- 1067US7563870B2LAGE-1 tumor associated nucleic acidsLUDWIG INST FOR CANCER RES LTD·Filed 2004·Granted Jul 21, 2009·0 cites·6 claims
- 1167US2021324061A1Garp-tgf-beta antibodiesARGENX BVBA·Filed 2020·Application pending·0 cites
- 1266US10604579B2Antibody against a complex between human GARP and latent TGF-βLUDWIG INST FOR CANCER RES LTD·Filed 2018·Granted Mar 31, 2020·0 cites·5 claims
- 1361US6271019B1Leukemia associated genesLUDWIG INST CANCER RES·Filed 1999·Granted Aug 7, 2001·13 cites·19 claims
- 1459US2025188161A1TGF-ß ANTIBODIESUNIV CATHOLIQUE LOUVAIN·Filed 2023·Application pending·0 cites
- 1555US2016251438A1Anti-garp protein and uses thereofARGEN-X N V·Filed 2016·Application pending·0 cites
- 1654US7022819B2Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereofLUDWIG INST CANCER RES·Filed 2002·Granted Apr 4, 2006·0 cites·2 claims
- 1753US5879892ALeukemia associated genesLUDWIG INST CANCER RES·Filed 1997·Granted Mar 9, 1999·10 cites·9 claims
- 1848US6475783B1Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereofLUDWIG INST CANCER RES·Filed 1998·Granted Nov 5, 2002·8 cites·17 claims
- 1948US5886145AIsolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereofINST NAT SANTE RECH MED·Filed 1997·Granted Mar 23, 1999·6 cites·6 claims
- 2043US2002176865A1Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B families and uses thereofFiled 2002·Application pending·0 cites
- 2142US6680191B1Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereofLUDWIG INST FOR CANCER·Filed 1999·Granted Jan 20, 2004·4 cites·16 claims
- 2241US6794131B1Lage-1 tumor associated nucleic acidsLUDWIG INST CANCER RES·Filed 1998·Granted Sep 21, 2004·3 cites·10 claims
- 2341US5997872AIsolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereofLUDWIG INST CANCER RES·Filed 1997·Granted Dec 7, 1999·5 cites·2 claims
- 2436US6027924AIsolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereofLUDWIG INST CANCER RES·Filed 1997·Granted Feb 22, 2000·1 cites·19 claims
- 2530US5958711AMethods for determining expression of NAG tumor rejection antigen precursorINST NAT SANTE RECH MED·Filed 1998·Granted Sep 28, 1999·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →